Bivalirudin Versus Heparin Monotherapy in ST-Segment-Elevation Myocardial Infarction.
Stefan K JamesSasha KoulJonas AnderssonOskar AngeråsPallonji BhiladvalaFredrik CalaisMikael DanielewiczOle FröbertPer GrimfjärdMatthias GötbergLoghman HenarehDan IoanesJens JensenRikard LinderPontus LindroosElmir OmerovicGeorgios PanayiTruls RåmunddalGiovanna SarnoAnders UlvenstamSebastian VöltzHenrik WagnerHelena WikströmOllie ÖstlundDavid ErlingePublished in: Circulation. Cardiovascular interventions (2021)
-inhibitors rate of the composite of all-cause death, MI, or major bleeding was not lower in those randomized to receive bivalirudin as compared with heparin. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02311231.
Keyphrases